Literature DB >> 22276606

Patients with thymomas have an increased risk of developing additional malignancies: lack of immunological surveillance?

Felice Granato1, Maria R Ambrosio, Donatella Spina, Stefano Lazzi, Bruno J Rocca, Luca Voltolini, Stefano Bongiolatti, Luca Luzzi, Giuseppe Gotti, Lorenzo Leoncini, Piero Tosi.   

Abstract

AIMS: To assess the risk, for patients with thymoma, of developing an additional malignancy (AM). METHODS AND
RESULTS: We studied 68 patients with thymomas. Based on the World Health Organization classification, the tumours were categorised as A, AB or B (B1, B2, B3) thymomas. Control populations comprised 114 patients with colorectal cancer, 108 patients with lymphoma and 123 patients with thyroid carcinoma. Patients with thymomas showed a higher risk of developing an AM (22 of 68 patients versus 11 of 114, eight of 108, and eight of 123 patients, respectively; P = 0.0002). The association between thymomas and AMs was related to the thymoma histotype, with B1, B2, B3 and AB tumours showing a higher risk of developing an AM than A thymomas (P = 0.0474).
CONCLUSIONS: Patients affected by thymomas showed a significantly higher risk of developing additional malignancies than those in the control groups, and cases that exhibited a predominantly cortical component were more likely to develop other neoplasms. This may be related to the functions of cortical thymic epithelial cells in providing for T lymphocyte maturation through interaction with major histocompatibility complexes.
© 2012 Blackwell Publishing Limited.

Entities:  

Mesh:

Year:  2012        PMID: 22276606     DOI: 10.1111/j.1365-2559.2011.04111.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  4 in total

1.  Deciphering the biology of thymic epithelial tumors.

Authors:  Arun Rajan; Chen Zhao
Journal:  Mediastinum       Date:  2019-09-17

Review 2.  Concurrent myasthenia gravis-related cervical thymoma in a patient with diffuse large B-cell lymphoma: a case report.

Authors:  Chutima Kunacheewa; Sattawut Wongwiangjunt; Sanya Sukpanichnant
Journal:  J Med Case Rep       Date:  2022-01-12

3.  Thymic Carcinomas and Second Malignancies: A Single-Center Review.

Authors:  Sunil S Badve; Rachel Dougherty; Michael Balatico; Kenneth A Kesler; Patrick Loehrer; Yesim Gökmen-Polar
Journal:  Cancers (Basel)       Date:  2021-05-19       Impact factor: 6.639

4.  Molecular analysis of thymoma.

Authors:  Sunil Badve; Chirayu Goswami; Yesim Gökmen-Polar; Robert P Nelson; John Henley; Nick Miller; Narjis A Zaheer; George W Sledge; Lang Li; Kenneth A Kesler; Patrick J Loehrer
Journal:  PLoS One       Date:  2012-08-13       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.